Management of Chronic Neuropathic Pain with Single and Compounded Topical Analgesics

References

• Anitescu M , BenzonHT , ArgoffCE . Advances in topical analgesics . Curr. Opin. Anaesthesiol.26 ( 5 ), 555 – 561 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Taxonomy ITFO . Classification of Chronic Pain (2nd Edition) . MerskeyH , BogdukN ( Eds ). IASP Press , WA, USA ( 1994 ).
   Google Scholar
• Smith BH , TorranceN . Epidemiology of neuropathic pain and its impact on quality of life . Curr. Pain Headache Rep.16 ( 3 ), 191 – 198 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Van Hecke O , AustinSK , KhanRA , SmithBH , TorranceN . Neuropathic pain in the general population: a systematic review of epidemiological studies . Pain155 ( 4 ), 654 – 662 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Sawynok J . Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development . Eur. J. Pain18 ( 4 ), 465 – 481 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mick G , BaronR , FinnerupNBet al. What is localized neuropathic pain? A first proposal to characterize and define a widely used term . Pain Manag.2 ( 1 ), 71 – 77 ( 2012 ).
   PubMedGoogle Scholar
• Jensen TS , MadsenCS , FinnerupNB . Pharmacology and treatment of neuropathic pains . Curr. Opin. Neurol.22 ( 5 ), 467 – 474 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Costigan M , BefortK , KarchewskiLet al. Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury . BMC Neurosci.3 , 16 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Latremoliere A , WoolfCJ . Central sensitization: a generator of pain hypersensitivity by central neural plasticity . J. Pain10 ( 9 ), 895 – 926 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Kolesnikov Y , El-MaaroufA , RutishauserU , PasternakG . Reorganization of dorsal root ganglion neurons following chronic sciatic nerve constriction injury: correlation with morphine and lidocaine analgesia . Eur. J. Pharmacol.568 ( 1–3 ), 124 – 133 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Baron R , HansG , DickensonAH . Peripheral input and its importance for central sensitization . Ann. Neurol.74 ( 5 ), 630 – 636 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Keppel Hesselink JM , KopskyDJ . Topical phenytoin in neuralgic pain, peripheral modulation of central sensitization: two case reports . J. Pain Relief6 ( 2 ), 1000284 ( 2017 ).
   Google Scholar
• Devigili G , TugnoliV , PenzaPet al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology . Brain131 ( Pt 7 ), 1912 – 1925 ( 2008 ).
   PubMedGoogle Scholar
• Lumpkin EA , CaterinaMJ . Mechanisms of sensory transduction in the skin . Nature445 ( 7130 ), 858 – 865 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Zhao P , BarrTP , HouQet al. Voltage-gated sodium channel expression in rat and human epidermal keratinocytes: evidence for a role in pain . Pain139 ( 1 ), 90 – 105 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Park HJ , MoonDE . Pharmacologic management of chronic pain . Korean J. Pain23 ( 2 ), 99 – 108 ( 2010 ).
   PubMedGoogle Scholar
• Peppin JF , AlbrechtPJ , ArgoffCet al. Skin matters: a review of topical treatments for chronic pain. Part two: treatments and applications . Pain Ther.4 ( 1 ), 33 – 50 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Stanos SP . Topical agents for the management of musculoskeletal pain . J. Pain Symptom Manage.33 ( 3 ), 342 – 355 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Galer BS . Topical medication . In : Bonica’s Managment of Pain . LoeserJD , ButlerSH , ChapmanCR , TurkDC ( Eds ). Lippincott Williams & Wilkins , PA, USA , 1736 – 1742 ( 2001 ).
   Google Scholar
• Jeal W , BenfieldP . Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control . Drugs53 ( 1 ), 109 – 138 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Durand C , AlhammadA , WillettKC . Practical considerations for optimal transdermal drug delivery . Am. J. Health Syst. Pharm.69 ( 2 ), 116 – 124 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Keppel Hesselink JM , KopskyDJ , BhaskarAK . Skin matters! The role of keratinocytes in nociception: a rational argument for the development of topical analgesics . J. Pain Res.10 , 1 – 8 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Peppin JF , AlbrechtPJ , ArgoffCet al. Skin matters: a review of topical treatments for chronic pain. Part one: skin physiology and delivery systems . Pain Ther.4 ( 1 ), 17 – 32 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zempsky W . Topical analgesics in treating neuropathic and musculoskeletal pain . Pain Med. News11 , 7 – 10 ( 2013 ).
   Google Scholar
• Pixgood . Sensory receptors in skin ( 2017 ). http://pixgood.com/sensory-receptors-in-skin.html .
   Google Scholar
• Elias PM . Stratum corneum defensive functions: an integrated view . J. Invest. Dermatol.125 ( 2 ), 183 – 200 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Baroli B . Penetration of nanoparticles and nanomaterials in the skin: fiction or reality?J. Pharm. Sci.99 ( 1 ), 21 – 50 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Barry BW . Breaching the skin’s barrier to drugs . Nat. Biotechnol.22 ( 2 ), 165 – 167 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Hadgraft J , LaneME . Skin permeation: the years of enlightenment . Int. J. Pharm.305 ( 1–2 ), 2 – 12 ( 2005 ).
   PubMedGoogle Scholar
• Van Hal DA , JeremiasseE , JungingerHE , SpiesF , BouwstraJA . Structure of fully hydrated human stratum corneum: a freeze-fracture electron microscopy study . J. Invest. Dermatol.106 ( 1 ), 89 – 95 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Cevc G , BlumeG . Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force . Biochim. Biophys. Acta1104 ( 1 ), 226 – 232 ( 1992 ).
   PubMed Web of Science ®Google Scholar
• Reed JT , GhadiallyR , EliasPM . Skin type, but neither race nor gender, influence epidermal permeability barrier function . Arch. Dermatol.131 ( 10 ), 1134 – 1138 ( 1995 ).
   PubMedGoogle Scholar
• Ghadially R . Aging and the epidermal permeability barrier: implications for contact dermatitis . Am. J. Contact Dermat.9 ( 3 ), 162 – 169 ( 1998 ).
   PubMedGoogle Scholar
• Ohta H , MakitaK , KawashimaT , KinoshitaS , TakenouchiM , NozawaS . Relationship between dermato-physiological changes and hormonal status in pre-, peri-, and postmenopausal women . Maturitas30 ( 1 ), 55 – 62 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Moss GP , DeardenJC , PatelH , CroninMT . Quantitative structure–permeability relationships (QSPRs) for percutaneous absorption . Toxicol. In vitro16 ( 3 ), 299 – 317 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Scheuplein R . Permeability of the skin: a review of major concepts and some new developments . J. Invest. Dermatol.67 ( 5 ), 672 – 676 ( 1976 ).
   Web of Science ®Google Scholar
• Keppel Hesselink JM , KopskyDJ , StahlSM . Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and Phase III design . J. Pain Res.10 , 635 – 641 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Pandey M , BelgamwarV , GattaniS , SuranaS , TekadeA . Pluronic lecithin organogel as a topical drug delivery system . Drug Deliv.17 ( 1 ), 38 – 47 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Pershing LK , BakhtianS , PonceletCE , CorlettJL , ShahVP . Comparison of skin stripping, in vitro release, and skin blanching response methods to measure dose response and similarity of triamcinolone acetonide cream strengths from two manufactured sources . J. Pharm. Sci.91 ( 5 ), 1312 – 1323 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Pershing LK , CorlettJL , NelsonJL . Comparison of dermatopharmacokinetic vs. clinicial efficacy methods for bioequivalence assessment of miconazole nitrate vaginal cream, 2% in humans . Pharm. Res.19 ( 3 ), 270 – 277 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Pershing L , LambertL , ShahV , LamSY . Variability and correlation of chromameter and tape-stripping methods with the visual skin blanching assay in the quantitative assessment of topical 0.05% betamethasone dipropionate bioavailability in humans . Int. J. Pharm.86 ( 2–3 ), 201 – 210 ( 1992 ).
   Google Scholar
• Craig AD . How do you feel? Interoception: the sense of the physiological condition of the body . Nat. Rev. Neurosci.3 ( 8 ), 655 – 666 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Cauna N . The free penicillate nerve endings of the human hairy skin . J. Anat.115 ( Pt 2 ), 277 – 288 ( 1973 ).
   PubMedGoogle Scholar
• Smith H , BrooksJR . Capsaicin-based therapies for pain control . Prog. Drug Res.68 , 129 – 146 ( 2014 ).
   PubMedGoogle Scholar
• Szallasi A , BlumbergPM . Vanilloid (capsaicin) receptors and mechanisms . Pharmacol. Rev.51 ( 2 ), 159 – 212 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Szallasi A , NilssonS , Farkas-SzallasiT , BlumbergPM , HokfeltT , LundbergJM . Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment . Brain Res.703 ( 1–2 ), 175 – 183 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Tominaga M , CaterinaMJ , MalmbergABet al. The cloned capsaicin receptor integrates multiple pain-producing stimuli . Neuron21 ( 3 ), 531 – 543 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Dhaka A , UzzellV , DubinAEet al. TRPV1 is activated by both acidic and basic pH . J. Neurosci.29 ( 1 ), 153 – 158 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Niiyama Y , KawamataT , YamamotoJ , OmoteK , NamikiA . Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons . Neuroscience148 ( 2 ), 560 – 572 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Facer P , CasulaMA , SmithGDet al. Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy . BMC Neurol.7 , 11 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Miller MS , BuckSH , SipesIG , BurksTF . Altered axoplasmic transport of nerve growth factor by capsaicin . Proc. West. Pharmacol. Soc.25 , 87 – 88 ( 1982 ).
   PubMedGoogle Scholar
• Watanabe N , HorieS , SpinaD , MichaelGJ , PageCP , PriestleyJV . Immunohistochemical localization of transient receptor potential vanilloid subtype 1 in the trachea of ovalbumin-sensitized guinea pigs . Int. Arch. Allergy Immunol.146 ( Suppl. 1 ), 28 – 32 ( 2008 ).
   PubMedGoogle Scholar
• Anand P , BleyK . Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch . Br. J. Anaesth.107 ( 4 ), 490 – 502 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bevan S , SzolcsanyiJ . Sensory neuron-specific actions of capsaicin: mechanisms and applications . Trends Pharmacol. Sci.11 ( 8 ), 330 – 333 ( 1990 ).
   PubMed Web of Science ®Google Scholar
• Han P , McdonaldHA , BianchiBRet al. Capsaicin causes protein synthesis inhibition and microtubule disassembly through TRPV1 activities both on the plasma membrane and intracellular membranes . Biochem. Pharmacol.73 ( 10 ), 1635 – 1645 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Bley K . Effect of topical capsaicin on cutaneous innervation: implications for the pain management . Open Pain J.6 ( Suppl. 1 ), 81 – 94 ( 2013 ).
   Google Scholar
• Holzer P . Neural injury, repair, and adaptation in the GI tract. II. The elusive action of capsaicin on the vagus nerve . Am. J. Physiol.275 ( 1 Pt 1 ), G8 – G13 ( 1998 ).
   PubMedGoogle Scholar
• Malmberg AB , MizisinAP , CalcuttNA , Von SteinT , RobbinsWR , BleyKR . Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch . Pain111 ( 3 ), 360 – 367 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Kennedy WR , VanhoveGF , LuSPet al. A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers . J. Pain11 ( 6 ), 579 – 587 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Fields HL , RowbothamM , BaronR . Postherpetic neuralgia: irritable nociceptors and deafferentation . Neurobiol. Dis.5 ( 4 ), 209 – 227 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Campbell JN , MeyerRA . Mechanisms of neuropathic pain . Neuron52 ( 1 ), 77 – 92 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Katz DB , SimonSA , MoodyA , NicolelisMA . Simultaneous reorganization in thalamocortical ensembles evolves over several hours after perioral capsaicin injections . J. Neurophysiol.82 ( 2 ), 963 – 977 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Wager TD , AtlasLY . The neuroscience of placebo effects: connecting context, learning and health . Nat. Rev. Neurosci.16 ( 7 ), 403 – 418 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Pershing LK , ReillyCA , CorlettJL , CrouchDJ . Effects of vehicle on the uptake and elimination kinetics of capsaicinoids in human skin in vivo . Toxicol. Appl. Pharmacol.200 ( 1 ), 73 – 81 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Neurogesx . Qutenza® (Capsaicin 8% Patch) for management of neuropathic pain associated with human immunodeficiency virus-associated peripheral neuropathy . Briefing Document for the Anesthesia and Analgesia Drug Products ( 2012 ).
   Google Scholar
• Chaiyasit K , KhovidhunkitW , WittayalertpanyaS . Pharmacokinetic and the effect of capsaicin in Capsicum frutescens on decreasing plasma glucose level . J. Med. Assoc. Thai.92 ( 1 ), 108 – 113 ( 2009 ).
   PubMedGoogle Scholar
• Peppin JF , MajorsK , WebsterLR , SimpsonDM , TobiasJK , VanhoveGF . Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain . J. Pain Res.4 , 385 – 392 ( 2011 ).
   PubMedGoogle Scholar
• Bhaskar AK , EnglandJ , LoweJ . Management of neuropathic pain using the capsaicin 8% patch in patients with cancer . Proceedings of the 7th World Research Congress of the European Association of Palliative Care . Trondheim, Norway , 7–9 June 2012 .
   Google Scholar
• Kem KU , PooleC , NowackW . Treatment of neuropathic pain with the capsaicin 8% patch (QUTENZA™): is pretreatment with lidocaine necessary?Proceedings of Pain in Europe 7th Congress of the European Federation of IASP Chapters . Hamburg, Germany , 21–24 September 2011 .
   Google Scholar
• Wagner T , PooleC , Roth-DaniekA . The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis . Pain Med.14 ( 8 ), 1202 – 1211 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• England J , WagnerT , KernKU , Roth-DaniekA , SellA . The capsaicin 8% patch for peripheral neuropathic pain . Br. J. Nurs.20 ( 15 ), 926 – 931 ( 2011 ).
   PubMedGoogle Scholar
• Derry S , RiceAS , ColeP , TanT , MooreRA . Topical capsaicin (high concentration) for chronic neuropathic pain in adults . Cochrane Database Syst. Rev.1 , CD007393 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Derry S , MooreRA . Topical capsaicin (low concentration) for chronic neuropathic pain in adults . Cochrane Database Syst. Rev. ( 9 ), CD010111 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kulkantrakorn K , LorsuwansiriC , MeesawatsomP . 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial . Pain Pract.13 ( 6 ), 497 – 503 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Martini CH , YassenA , Krebs-BrownAet al. A novel approach to identify responder subs and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia . Eur. J. Pain17 ( 10 ), 1491 – 1501 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Simpson DM , BrownS , TobiasJ , NGX-4010 C107 Study . Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy . Neurology70 ( 24 ), 2305 – 2313 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Maihofner C , HeskampML . Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study . Curr. Med. Res. Opin.29 ( 6 ), 673 – 683 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Clifford DB , SimpsonDM , BrownSet al. A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy . J. Acquir. Immune Defic. Syndr.59 ( 2 ), 126 – 133 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Irving G , BackonjaM , RauckR , WebsterLR , TobiasJK , VanhoveGF . NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia . Clin. J. Pain28 ( 2 ), 101 – 107 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Webster LR , PeppinJF , MurphyFT , LuB , TobiasJK , VanhoveGF . Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain . Diabetes Res. Clin. Pract.93 ( 2 ), 187 – 197 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Backonja MM , MalanTP , VanhoveGF , TobiasJK , C102/106 Study . NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension . Pain Med.11 ( 4 ), 600 – 608 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Wehrfritz A , NamerB , IhmsenHet al. Differential effects on sensory functions and measures of epidermal nerve fiber density after application of a lidocaine patch (5%) on healthy human skin . Eur. J. Pain15 ( 9 ), 907 – 912 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Rowbotham MC , DaviesPS , VerkempinckC , GalerBS . Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia . Pain65 ( 1 ), 39 – 44 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Devers A , GalerBS . Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study . Clin. J. Pain16 ( 3 ), 205 – 208 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Argoff CE . Topical analgesics in the management of acute and chronic pain . Mayo Clin. Proc.88 ( 2 ), 195 – 205 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Finnerup NB , AttalN , HaroutounianSet al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis . Lancet Neurol.14 ( 2 ), 162 – 173 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Navez ML , MonellaC , BoslI , SommerD , DelormeC . 5% lidocaine medicated plaster for the treatment of postherpetic neuralgia: a review of the clinical safety and tolerability . Pain Ther.4 ( 1 ), 1 – 15 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Inc EP . LIDODERM® (Lidocaine Patch 5%) ( 2015 ).
   Google Scholar
• Gammaitoni AR , AlvarezNA , GalerBS . Pharmacokinetics and safety of continuously applied lidocaine patches 5% . Am. J. Health Syst. Pharm.59 ( 22 ), 2215 – 2220 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Gammaitoni AR , DavisMW . Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing . Ann. Pharmacother.36 ( 2 ), 236 – 240 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Ltd G . Versatis 5% Medicated Plaster ( 2015 ). http://www.medicines.org.uk/emc/medicine/19291 .
   Google Scholar
• Krumova EK , ZellerM , WestermannA , MaierC . Lidocaine patch (5%) produces a selective, but incomplete block of Adelta and C fibers . Pain153 ( 2 ), 273 – 280 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Maier C , BaronR , TolleTRet al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes . Pain150 ( 3 ), 439 – 450 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Demant DT , LundK , FinnerupNBet al. Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype: a randomised, double-blind, and placebo-controlled, phenotype panel study . Pain156 ( 11 ), 2234 – 2244 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Hans G , SabatowskiR , BinderA , BoeslI , RogersP , BaronR . Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study . Curr. Med. Res. Opin.25 ( 5 ), 1295 – 1305 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Baron R , MayoralV , LeijonG , BinderA , SteigerwaldI , SerpellM . Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy . Curr. Med. Res. Opin.25 ( 7 ), 1677 – 1687 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Baron R , MayoralV , LeijonG , BinderA , SteigerwaldI , SerpellM . 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study . Curr. Med. Res. Opin.25 ( 7 ), 1663 – 1676 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Barbano RL , HerrmannDN , Hart-GouleauS , Pennella-VaughanJ , LodewickPA , DworkinRH . Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy . Arch. Neurol.61 ( 6 ), 914 – 918 ( 2004 ).
   PubMedGoogle Scholar
• Galer BS , RowbothamMC , PeranderJ , FriedmanE . Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study . Pain80 ( 3 ), 533 – 538 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Estanislao L , CarterK , McArthurJ , OlneyR , SimpsonD , LidodermHIVNG . A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy . J. Acquir. Immune Defic. Syndr.37 ( 5 ), 1584 – 1586 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Herrmann DN , BarbanoRL , Hart-GouleauS , Pennella-VaughanJ , DworkinRH . An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy . Pain Med.6 ( 5 ), 379 – 384 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Galer BS , JensenMP , MaT , DaviesPS , RowbothamMC . The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale . Clin. J. Pain18 ( 5 ), 297 – 301 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Mico JA , ArdidD , BerrocosoE , EschalierA . Antidepressants and pain . Trends Pharmacol. Sci.27 ( 7 ), 348 – 354 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Ho KY , HuhBK , WhiteWD , YehCC , MillerEJ . Topical amitriptyline versus lidocaine in the treatment of neuropathic pain . Clin. J. Pain24 ( 1 ), 51 – 55 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Lynch ME , ClarkAJ , SawynokJ , SullivanMJ . Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial . Anesthesiology103 ( 1 ), 140 – 146 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Ness TJ , JonesL , SmithH . Use of compounded topical analgesics – results of an Internet survey . Reg. Anesth. Pain Med.27 ( 3 ), 309 – 312 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Hiom S , PatelGK , NewcombeRG , KhotS , MartinC . Severe postherpetic neuralgia and other neuropathic pain syndromes alleviated by topical gabapentin . Br. J. Dermatol.173 ( 1 ), 300 – 302 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Shahid M , SubhanF , AhmadNet al. Topical gabapentin gel alleviates allodynia and hyperalgesia in the chronic sciatic nerve constriction injury neuropathic pain model . Eur. J. Pain21 ( 4 ), 668 – 680 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Kopsky DJ , Keppel HesselinkJM . Neuropathic pain as a result of acromegaly, treated with topical baclofen cream . J. Pain Symptom Manage.46 ( 4 ), e4 – e5 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Reis GM , DuarteID . Baclofen, an agonist at peripheral GABAB receptors, induces antinociception via activation of TEA-sensitive potassium channels . Br. J. Pharmacol.149 ( 6 ), 733 – 739 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Whitehead RA , PuilE , RiesCRet al. GABA(B) receptor-mediated selective peripheral analgesia by the non-proteinogenic amino acid, isovaline . Neuroscience213 , 154 – 160 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kopsky DJ , Keppel HesselinkJM . Phenytoin in topical formulations augments pain reduction of other topically applied analgesics in the treatment of trigeminal neuralgia . J. Clin. Anesth.38 , 154 – 155 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Kopsky DJ , Keppel HesselinkJM . Topical phenytoin for the treatment of neuropathic pain . J. Pain Res.10 , 469 – 473 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Tetreault P , BalikiM , Vachon-PresseauE , YeastedRE , SchnitzerTJ , ApkarianAV . Cortical reorganization after duloxetine treatment-related pain decrease in knee osteoarthritis . Presented at : ACP/ARHP Annual Meeting . MA, USA , 14–19 November 2014 ( Abstract 925 ).
   Google Scholar
• Wu CL , TellaP , StaatsPSet al. Analgesic effects of intravenous lidocaine and morphine on postamputation pain: a randomized double-blind, active placebo-controlled, crossover trial . Anesthesiology96 ( 4 ), 841 – 848 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Reich DL , SilvayG . Ketamine: an update on the first twenty-five years of clinical experience . Can. J. Anaesth.36 ( 2 ), 186 – 197 ( 1989 ).
   PubMed Web of Science ®Google Scholar
• Mion G , VillevieilleT . Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings) . CNS Neurosci. Ther.19 ( 6 ), 370 – 380 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kopsky DJ , Keppel HesselinkJM , BhaskarA , HaritonG , RomanenkoV , CasaleR . Analgesic effects of topical ketamine . Minerva Anestesiol81 ( 4 ), 440 – 449 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Sawynok J . Topical and peripheral ketamine as an analgesic . Anesth. Analg.119 ( 1 ), 170 – 178 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Guirimand F , DupontX , BrasseurL , ChauvinM , BouhassiraD . The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive flexion reflex and pain in humans . Anesth. Analg.90 ( 2 ), 408 – 414 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Gordh T , KarlstenR , KristensenJ . Intervention with spinal NMDA, adenosine, and NO systems for pain modulation . Ann. Med.27 ( 2 ), 229 – 234 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Roelofs PD , DeyoRA , KoesBW , ScholtenRJ , Van TulderMW . Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review . Spine33 ( 16 ), 1766 – 1774 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Glinn MA , LickteigAJ , WeberLet al. Urinary concentrations of topically administered pain medications . J. Anal. Toxicol.41 ( 2 ), 127 – 133 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Michael L , WaisbrenS . Accidental overdose after intrarectal abuse of topical ketamine compound: a case report . Presented at : American Academy of Addiction Psychiatry Annual Meeting . CA, USA , 3–6 December 2015 .
   Google Scholar
• Neil MJ . Clonidine: clinical pharmacology and therapeutic use in pain management . Curr. Clin. Pharmacol.6 ( 4 ), 280 – 287 ( 2011 ).
   PubMedGoogle Scholar
• Riedl MS , SchnellSA , OverlandACet al. Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn . J. Comp. Neurol.513 ( 4 ), 385 – 398 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wrzosek A , WoronJ , DobrogowskiJ , Jakowicka-WordliczekJ , WordliczekJ . Topical clonidine for neuropathic pain . Cochrane Database Syst. Rev.8 , CD010967 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Dogrul A , UzbayIT . Topical clonidine antinociception . Pain111 ( 3 ), 385 – 391 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Khan ZP , FergusonCN , JonesRM . Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role . Anaesthesia54 ( 2 ), 146 – 165 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Campbell CM , KipnesMS , StouchBCet al. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy . Pain153 ( 9 ), 1815 – 1823 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Domino LE , DominoSE , StockstillMS . Relationship between plasma concentrations of clonidine and mean arterial pressure during an accidental clonidine overdose . Br. J. Clin. Pharmacol.21 ( 1 ), 71 – 74 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Raber JH , ShinarC , FinkelsteinS . Clonidine patch ingestion in an adult . Ann. Pharmacother.27 ( 6 ), 719 – 722 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Farooqi M , SeifertS , KunkelS , JohnsonM , BensonB . Toxicity from a clonidine suspension . J. Med. Toxicol.5 ( 3 ), 130 – 133 ( 2009 ).
   PubMedGoogle Scholar
• Romano MJ , DinhA . A 1000-fold overdose of clonidine caused by a compounding error in a 5 year-old child with attention-deficit/hyperactivity disorder . Pediatrics108 ( 2 ), 471 – 472 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Pomerleau AC , GoodenCE , FantzCR , MorganBW . Dermal exposure to a compounded pain cream resulting in severely elevated clonidine concentration . J. Med. Toxicol.10 ( 1 ), 61 – 64 ( 2014 ).
   PubMedGoogle Scholar
• Mccarberg B , D’arcyY . Options in topical therapies in the management of patients with acute pain . Postgrad. Med.125 ( 4 Suppl. 1 ), 19 – 24 ( 2013 ).
   PubMedGoogle Scholar